BDX logo

BDX

Profile

Full Name

Becton, Dickinson and Company

Ticker Symbol

BDX

Exchange

NYSE

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

February 21, 1973

Indexes

S&P 500

Website

http://www.bd.com

Employees

70000

Key Details

Price

$204.45(+1.05%)

Market cap

Last Dividend

$1.04

TTM Dividend yield

1.95%

Annual revenue

$20.18B(+4.16% YoY)

Annual EPS

$5.86(+18.62% YoY)

PE ratio

33.96

Next earnings date

May 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$204.45
BDX price is $204.45

30-Day Relative Volume

0.56
BDX 30-day relative volume is 0.56

Price Performance

Price Most recent change

+1.05%
BDX price was up +1.05% on Apr 24, 2025

Price YTD change

-9.88%
BDX price is down -9.88% since January 1st

Price 1-year change

-11.29%
BDX price is down -11.29% year-on-year

Price 3-year change

-20.9%
BDX price is down -20.9% over the past 3 years

Price Range

Price All-time high

$287.32
BDX price is currently -28.84% below its historical high of $287.32

Price 3-year low

$193.03
BDX price is currently +5.92% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$58.70B
BDX market capitalization is $58.70 billion

Market cap 3-year change

-20.32%
BDX market capitalization is down -20.32% over the past 3 years

Market cap All-time high

$82.27B
BDX market capitalization is currently -28.65% below its historical high of $82.27 billion

Market cap sector rank

97.6%
BDX market capitalization is higher than 97.6% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-0.65%
BDX shares outstanding is down -0.65% year-on-year

Shares Outstanding 3-Year Change

+0.73%
BDX shares outstanding is up +0.73% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.42
BDX beta is 0.42

200-day SMA

$230.33
BDX price is currently -11.23% below its 200-day simple moving average

50-day SMA

$220.20
BDX price is currently -7.15% below its 50-day simple moving average

RSI

41.80
BDX 14-day relative strength index is 41.80

Volume

0.56
BDX 30-day relative volume is 0.56

ATR

$5.58
BDX average true range is $5.58

10-day Historical Volatility

33.48%
BDX 10-day historical volatility is 33.48%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$1.04
BDX last dividend was $1.04 per share, with an ex-dividend date of March 10, 2025

Next Dividend

-
BDX next dividend has not yet been announced

Dividend per share

Dividend per share

$3.80
BDX annual dividend per share is $3.80

Dividend per share Sector Rank

89.66%
BDX annual dividend per share is higher than 89.66% of companies in Healthcare sector

Dividend per share 1-Year Change

+4.4%
BDX annual dividend per share is up +4.4% year-on-year

Dividend per share 3-Year Change

+14.46%
BDX annual dividend per share is up +14.46% over the past 3 years

Dividend yield

Dividend yield

1.86%
BDX annual dividend yield is 1.86%

Dividend yield Sector Rank

46.51%
BDX annual dividend yield is higher than 46.51% of companies in Healthcare sector

Other

Payout ratio

64.52%
BDX annual payout ratio is 64.52%

Dividends paid

$1.10B
BDX annual dividends paid is $1.10 billion

Free cash flow

$3.07B
BDX annual free cash flow is $3.07 billion

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$20.18B
BDX annual revenue is $20.18 billion

Revenue Analysts estimate

$21.81B
BDX annual revenue is currently -7.47% lower than the consensus analysts' forecast

Revenue 1-year change

+4.16%
BDX annual revenue is up +4.16% year-on-year

Revenue Sector rank

96.25%
BDX annual revenue is higher than 96.25% of companies in Healthcare sector

EPS

EPS

$5.86
BDX annual earnings per share is $5.86

EPS Analysts estimate

$14.37
BDX annual earnings per share is currently -59.23% lower than the consensus analysts' forecast

EPS 1-year change

+18.62%
BDX annual earnings per share is up +18.62% year-on-year

EPS Sector rank

96.41%
BDX annual earnings per share is higher than 96.41% of companies in Healthcare sector

Profit

Gross profit

$9.15B
BDX annual gross profit is $9.15 billion

Gross margin

45.36%
BDX annual gross profit margin is 45.36%

Operating profit

$2.88B
BDX annual operating income is $2.88 billion

Operating margin

14.29%
BDX annual operating profit margin is 14.29%

Net income

$1.71B
BDX annual net profit is $1.71 billion

Net margin

8.55%
BDX annual net profit margin is 8.55%

Expenses

Total expenses

$17.29B
BDX annual total expenses is $17.29 billion

Operating expenses

$6.27B
BDX annual total operating expenses is $6.27 billion

Cost of goods sold

$11.03B
BDX annual cost of goods sold is $11.03 billion

Selling, general & administrative expenses

$4.86B
BDX annual SGA is $4.86 billion

Depreciation and amortization

$2.29B
BDX annual depreciation & amortization is $2.29 billion

Interest expense

$528.00M
BDX annual interest expense is $528.00 million

Income tax

$307.00M
BDX annual income tax is $307.00 million

EBIT & EBITDA

EBIT

$2.56B
BDX annual earnings before interest & taxes is $2.56 billion

EBITDA

$4.85B
BDX annual EBITDA is $4.85 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$57.29B
BDX annual total assets is $57.29 billion

Non current assets

$46.82B
BDX annual long term assets is $46.82 billion

Current assets

$10.47B
BDX annual total current assets is $10.47 billion

Cash and cash equivalents

$1.72B
BDX annual cash & cash equivalents is $1.72 billion

Accounts receivable

$3.03B
BDX annual accounts receivable is $3.03 billion

Inventory

$3.84B
BDX annual inventory is $3.84 billion

Liabilities

Total liabilities

$31.40B
BDX annual total liabilities is $31.40 billion

Long term liabilities

$22.43B
BDX annual total long term liabilities is $22.43 billion

Current liabilities

$8.95B
BDX annual total current liabilities is $8.95 billion

Accounts payable

$1.90B
BDX annual accounts payable is $1.90 billion

Debt

Total debt

$20.11B
BDX annual total debt is $20.11 billion

Total debt 1-year change

+26.65%
BDX annual total debt is up +26.65% year-on-year

Long term debt

$17.94B
BDX annual long term debt is $17.94 billion

Short term debt

$2.17B
BDX annual short term debt is $2.17 billion

Equity & Capital

Shareholders equity

$25.89B
BDX annual stockholders equity is $25.89 billion

Book value

$25.91B
BDX annual book value is $25.91 billion

Retained earnings

$16.14B
BDX annual retained earnings is $16.14 billion

Working capital

$1.52B
BDX annual working capital is $1.52 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$3.80B
BDX annual cash flow from operations is $3.80 billion

Cash from operations 1-year change

+27.03%
BDX annual cash flow from operations is up +27.03% year-on-year

Cash from investing

-$5.51B
BDX annual cash flow from investing activities is -$5.51 billion

Cash from investing 1-year change

-670.11%
BDX annual cash flow from investing activities is down -670.11% year-on-year

Cash from financing

$2.09B
BDX annual cash flow from financing activities is $2.09 billion

Cash from financing 1-year change

+206.59%
BDX annual cash flow from financing activities is up +206.59% year-on-year

CAPEX

CAPEX

$725.00M
BDX annual capital expenditures is $725.00 million

CAPEX 1-year change

-17.05%
BDX annual capital expenditures is down -17.05% year-on-year

Free Cash Flow

Free cash flow

$3.07B
BDX annual free cash flow is $3.07 billion

Free cash flow 1-year change

+45.25%
BDX annual free cash flow is up +45.25% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

45.36%
BDX annual gross profit margin is 45.36%

Operating margin

14.29%
BDX annual operating profit margin is 14.29%

Net margin

8.55%
BDX annual net profit margin is 8.55%

ROA & ROE

ROA

3.10%
BDX annual return on assets is 3.10%

ROE

6.60%
BDX annual return on equity is 6.60%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

33.96
BDX price to earnings ratio is 33.96

PE ratio Sector rank

65.69%
BDX price to earnings ratio is higher than 65.69% of companies in Healthcare sector

PB Ratio

PB ratio

2.33
BDX price to book ratio is 2.33

PB ratio Sector rank

64.98%
BDX price to book ratio is higher than 64.98% of companies in Healthcare sector

PS Ratio

PS ratio

2.84
BDX price to sales ratio is 2.84

PS ratio Sector rank

48.18%
BDX price to sales ratio is higher than 48.18% of companies in Healthcare sector

Enterprise value

Enterprise value

$76.75B
BDX enterprise value is $76.75 billion

Enterprise value Sector rank

98.08%
BDX enterprise value is higher than 98.08% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

15.80
BDX EV/EBITDA is 15.80

EV/EBITDA Sector rank

88.48%
BDX EV/EBITDA is higher than 88.48% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.17
BDX annual current ratio is 1.17

Quick ratio

0.74
BDX annual quick ratio is 0.74

Leverage

Debt to equity

0.78
BDX annual debt to equity ratio is 0.78

Interest coverage ratio

4.85
BDX annual interest coverage ratio is 4.85

Risk & Stability

Piotroski F-Score

7
BDX piotroski f-score is 7

Altman Z-Score

2.05
BDX altman z-score is 2.05

Analyst ratings

Recent major analysts updates

Apr 23, 25 Piper Sandler
Overweight
Apr 7, 25 Barclays
Overweight
Feb 14, 25 Barclays
Overweight
Jan 28, 25 Piper Sandler
Overweight
Oct 1, 24 Evercore ISI Group
Outperform
Oct 1, 24 Citigroup
Buy
Aug 2, 24 Raymond James
Outperform
Jul 26, 24 Stifel
Buy
Jul 11, 24 Citigroup
Neutral
Jul 2, 24 Evercore ISI Group
Outperform

Institutional Ownership

Similar stocks

COR logo
Cencora (COR)
REGN logo
Regeneron Pharmaceuticals (REGN)
ZTS logo
Zoetis (ZTS)
TAK logo
Takeda Pharmaceutical Company Limited (TAK)
ALC logo
Alcon (ALC)
HLN logo
Haleon (HLN)
EW logo
Edwards Lifesciences (EW)
GSK logo
GSK (GSK)
VEEV logo
Veeva Systems (VEEV)
  • What is the ticker symbol for Becton Dickinson and Company?
  • Does Becton Dickinson and Company pay dividends?
  • What sector is Becton Dickinson and Company in?
  • What industry is Becton Dickinson and Company in?
  • What country is Becton Dickinson and Company based in?
  • When did Becton Dickinson and Company go public?
  • Is Becton Dickinson and Company in the S&P 500?
  • Is Becton Dickinson and Company in the NASDAQ 100?
  • Is Becton Dickinson and Company in the Dow Jones?
  • When was Becton Dickinson and Company's last earnings report?
  • When does Becton Dickinson and Company report earnings?
  • Should I buy Becton Dickinson and Company stock now?

What is the ticker symbol for Becton Dickinson and Company?

The ticker symbol for Becton Dickinson and Company is NYSE:BDX

Does Becton Dickinson and Company pay dividends?

Yes, Becton Dickinson and Company pays dividends. The last payment was $1.04, with an ex-dividend date on March 10, 2025

What sector is Becton Dickinson and Company in?

Becton Dickinson and Company is in the Healthcare sector

What industry is Becton Dickinson and Company in?

Becton Dickinson and Company is in the Medical Instruments & Supplies industry

What country is Becton Dickinson and Company based in?

Becton Dickinson and Company is headquartered in United States

When did Becton Dickinson and Company go public?

Becton Dickinson and Company's initial public offering (IPO) was on February 21, 1973

Is Becton Dickinson and Company in the S&P 500?

Yes, Becton Dickinson and Company is included in the S&P 500 index

Is Becton Dickinson and Company in the NASDAQ 100?

No, Becton Dickinson and Company is not included in the NASDAQ 100 index

Is Becton Dickinson and Company in the Dow Jones?

No, Becton Dickinson and Company is not included in the Dow Jones index

When was Becton Dickinson and Company's last earnings report?

Becton Dickinson and Company's most recent earnings report was on Feb 6, 2025

When does Becton Dickinson and Company report earnings?

The next expected earnings date for Becton Dickinson and Company is May 1, 2025

Should I buy Becton Dickinson and Company stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page